United States Senate : Support Alzheimer’s research that will save lives and millions of dollars
In a major advance, the U.S. House Appropriations Committee just approved an increase in Alzheimer's and dementia research funding. And while we are thankful for their actions, this funding increase is far from guaranteed until it is passed by both the Senate and signed into law by the President.
Very soon your Senators will have an opportunity to advance a similar measure in the U.S. Senate.
Please send a message to your U.S. Senators and urge them to support this funding increase.
Today, more than 5 million people are living with Alzheimer's, a number that is estimated to nearly triple by mid-century. Research is the only option to one day prevent and effectively treat Alzheimer's.
By sending a message today YOU can fight for the future of Alzheimer's research in America.
Please urge your Senator to support vital Alzheimer's research that will save lives and millions of dollars.
To United States Senate:
As an Alzheimer's Association advocate, I am writing to request that you support a $414 million increase for research funding at the National Institutes of Health (NIH) on Alzheimer's disease for FY 2018.
Alzheimer's is the only leading cause of death in America without a way to prevent, cure, or even slow its progression. What's more, according to the findings of an NIH-funded study that appeared in the New England Journal of Medicine, Alzheimer's is the most expensive disease in America. In 2017, the United States is estimated to spend $259 billion caring for individuals with Alzheimer's and other dementias, with $175 billion being borne by Medicare and Medicaid. This means nearly one out of five Medicare dollars is spent on a person with Alzheimer's. Unless we move quickly to address this crisis and find better treatments for those who have it, these costs will grow swiftly in lock step with the numbers of those affected, and Alzheimer's will increasingly overwhelm our health care system.
The $414 million increase for FY 2018 is consistent with the Alzheimer's Bypass Budget issued by the NIH. These funds will support additional research into developing innovative treatments and diagnostics that can help delay the onset of symptoms and ultimately cure Alzheimer's. It is critical to provide sufficient resources to implement a smart and strategic National Alzheimer's Plan. Without a continued substantial investment, our commitment to end Alzheimer's disease is simply an empty promise.
Because age is the greatest risk factor for Alzheimer's, the rapidly growing number of older Americans will lead to a corresponding rapid growth in the prevalence of Alzheimer's disease. The number of people living with Alzheimer's disease is projected to grow from more than 5 million today to as many as 16 million in 2050. One in 10 Americans over 65 has Alzheimer's, and the proportion of individuals affected rises with age.
Alzheimer's disease also poses an increasingly dire threat to our nation's fiscal future. We must decisively address this national epidemic. With increasing numbers of Americans affected by this devastating disease and its escalating impact on the federal budget, we simply must allocate resources to overcome this disease.